Sildenafil Citrate Orodispersible Tablet - Huiren / Likexin 50?mg Subtotal: $1.00
Carboplatin Injection (Qilu) – Wholesale & Retail (For Research Use Only)
$6.00
Carboplatin Injection (Qilu) supplies 100?mg freeze?dried vials for reconstitution. Produced by Qilu Pharmaceutical Co., Ltd., licensed under H10920028 and designed for laboratory research into DNA?alkylation, tumor cytotoxicity assays, chemotherapy resistance studies, and pharmacokinetic modeling. Supports both wholesale and retail. Strictly for research use only.?For wholesale prices, other specifications and uses, please consult our staff?
描述
Carboplatin is a second?generation platinum compound that forms DNA crosslinks to inhibit cell division. It offers a more favorable toxicity profile compared to cisplatin. In oncology research, Carboplatin Injection (Qilu) is utilized to model DNA damage response, drug resistance in cancer cells, renal-cleared exposure protocols (via area-under-curve dosing), and combination oncology assays. The product is supplied as 0.1?g freeze?dried powder per vial in packs of six. For laboratory research only.
Product Specifications
| Parameter | Detail |
|---|---|
| Product Name | Carboplatin Injection (Qilu) |
| Strength | 0.1?g per vial (lyophilized powder) |
| Packaging | 6 vials per box |
| Dosage Form | Freeze?dried powder for injection |
| Manufacturer | Qilu Pharmaceutical Co., Ltd. |
| Approval Number | ???? H10920028 |
| Drug Standard Code | 86904021000295 |
| Barcode | 6915798003635 |
| CAS Number | 41575?94?4 |
| Molecular Formula | C?H??N?O?Pt |
Mechanism of Action & Research Applications
Carboplatin induces intra- and inter-strand DNA cross-linking, preventing DNA replication and triggering apoptosis. It is widely used in laboratory research to study tumor cytotoxicity, DNA repair mechanisms, pharmacokinetics modeling (e.g., AUC-based dosing), and drug-resistance assays, including combination chemotherapy protocols. It’s particularly valuable for translation models of platinum chemistry in oncology research.
Side Effects (For Reference Only in Research Models)
Based on clinical-analog data, potential responses include bone marrow suppression (thrombocytopenia, neutropenia, anemia), mild nausea, fatigue, and possible allergic reactions. Carboplatin is notably less nephrotoxic than cisplatin, but caution is advised when designing dosing protocols, especially with renal clearance considerations.
Disclaimer
Carboplatin Injection (Qilu) is strictly intended for laboratory research use only. Not for human or veterinary therapeutic or diagnostic use.
其他信息
| 重量 | 0.6 公斤 |
|---|---|
| 尺寸 | 23 × 36 × 23 厘米 |
Q1: What is Carboplatin Injection (Qilu) used for in research?
A: Carboplatin Injection (Qilu) is used to model DNA damage response, simulate anticancer cytotoxic protocols, and study chemotherapeutic resistance in oncology laboratory assays.
Q2: How does Carboplatin Injection (Qilu) work in experimental models?
A: It crosslinks DNA to inhibit replication and induce apoptosis. Laboratory dosing can be calibrated using AUC-based pharmacokinetic models to mimic clinical exposure levels.
Q3: Why choose Carboplatin Injection (Qilu) for research?
A: The product is manufactured under regulatory approval (H10920028) by an established manufacturer (Qilu) and provides consistent purity and formulation, making it ideal for reproducible experimental use.
Q4: Which research applications commonly use Carboplatin Injection (Qilu)?
A: Common uses include DNA repair assays, tumor cell viability studies, combination chemotherapy screening, and pharmacokinetic modeling in preclinical research.
Q5: Can I order Carboplatin Injection (Qilu) in bulk?
A: Yes, wholesale and retail orders are supported. Contact us for pricing, minimum order quantity, and logistics information.
Q6: How should Carboplatin Injection (Qilu) be stored for research use?
A: Store lyophilized vials at controlled room temperature in a dry environment. Reconstituted solutions should be used immediately or stored under sterile refrigeration as per lab protocols.
Q7: Can Carboplatin Injection (Qilu) be used with other research agents?
A: Yes, it is frequently combined with taxanes, radiation models, or DNA repair inhibitors in synergy and resistance studies.
Q8: What adverse observations may appear in models using Carboplatin Injection (Qilu)?
A: Potential observations include marrow suppression, mild systemic symptoms (nausea, fatigue), and possible allergic markers; use these as reference in safety and dose guidance.
Q9: Is Carboplatin Injection (Qilu) approved for clinical use?
A: It is approved in China under licence H10920028. However, this product listing is strictly for laboratory research use only and not intended for therapeutic application.
相关产品
-
Regorafenib Tablets (Reodixin®) – 40?mg
Regorafenib (Reodixin®) is an oral multi-kinase inhibitor targeting angiogenesis, proliferation, metastasis, and tumor immunity. FDA-approved for several advanced solid tumors. Here offered as 40?mg tablets in a 28-count bottle—strictly for laboratory research use only $1.00 -
Granisetron Hydrochloride Dispersible Tablets Price comparison
A 5-HT? receptor antagonist—Granisetron Hydrochloride Dispersible Tablets by Guangxi Mingjian Pharmaceutical Co., Ltd. (Guimingjian). Packaged as 1?mg tablets, 4 tablets per blister × 2 blisters per box. Approved in China (NMPA No. H20020303; product code 86905130000183). Primarily intended for clinical prevention and treatment of nausea/vomiting induced by chemotherapy, radiation, or surgery. For research use only $1.00 -
Elranatamab Injection 76?mg/1.9?mL/Freeze-dried powder
Elranatamab (ELREXFIO®) is a BCMA-CD3 bispecific antibody used in multiple myeloma research. Supplied as a 76?mg/1.9?mL single-dose vial, manufactured by Pfizer. Approved by FDA (Aug?2023) and EMA (Dec?2023). Ideal for oncology, immunotherapy, and T?cell engager studies.
$1.00
?? For laboratory research use only – Not for human consumption or therapeutic use. -
Letrozole Capsules (Qipuyi®) – 2.5?mg?wholesale Price comparison
Letrozole is a potent nonsteroidal aromatase inhibitor, produced by Qilu Pharmaceutical Co., Ltd. (Qipuyi® brand). Each box contains 30 capsules (2.5?mg each), packaged as 3 blister cards. It’s approved in China under NMPA No.?H20213680, code 86981659000019, with barcodes 6915798005257 and 6915798005721. Strictly for laboratory research use—not for clinical or human applications. $1.00
评价
目前还没有评价